We are live on
!
Find out more
Puma Biotechnology
PBYI
PBYI
149 hedge funds and large institutions have $2B invested in Puma Biotechnology in 2016 Q3 according to their latest regulatory filings, with 55 funds opening new positions, 37 increasing their positions, 41 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
244% more first-time investments, than exits
New positions opened: 55 | Existing positions closed: 16
112% more capital invested
Capital invested by funds: $948M → $2B (+$1.06B)
35% more funds holding
Funds holding: 110 → 149 (+39)
14% more call options, than puts
Call options by funds: $36.2M | Put options by funds: $31.8M
10% less repeat investments, than reductions
Existing positions increased: 37 | Existing positions reduced: 41
5.56% less ownership
Funds ownership: 97.9% → 92.34% (-5.6%)
Holders
149
Holders Change
+39
Holders Change %
+35.45%
% of All Funds
3.98%
Holding in Top 10
3
Holding in Top 10 Change
+3
Holding in Top 10 Change %
% of All Funds
0.08%
New
55
Increased
37
Reduced
41
Closed
16
Calls
$36.2M
Puts
$31.8M
Net Calls
+$4.38M
Net Calls Change
+$7.29M
Top Buyers
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$34.9M |
| 2 |
RG
Redmile Group
San Francisco,
California
|
+$33.5M |
| 3 |
American Century Companies
Kansas City,
Missouri
|
+$33M |
| 4 |
Millennium Management
New York
|
+$28.1M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
+$10.8M |
